All News

Staying positive while receiving cancer treatment for non-Hodgkin lymphoma helped me feel grateful for happy moments.

Patients who received systemic therapy at the end of life did not have longer overall survival averages than those who did not receive therapy at end of life.

The Food and Drug Administration approved Keytruda plus chemotherapy, followed by single-agent Keytruda for primary advanced or recurrent endometrial cancer.

Experiencing losing a friend to cancer in the cancer community is never easy, but it’s OK to allow your heart to break.

Data show that patients’ multiple myeloma still fails to progress if patients receive less-frequent Tecvayli.

Approximately half of the patients with MDS who responded to treatment with Rytelo went a year without needing a blood transfusion, one expert explained.

Increased awareness and support may be one of the many ways to help decrease the impact of disparities in multiple myeloma.

Medical school didn't teach me how to help patients find hope during tough times.

To ensure best outcomes, patients with chronic myeloid leukemia should maintain frequent communication with their care teams — even between appointments.

Within the genitourinary cancer space, there have been many treatment advances over the past year.

Most — though not all — side effects from chronic myeloid leukemia treatment improve over time, an expert said.

The FDA approved Blincyto for patients aged one month and older with CD19-positive, Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

A chronic myeloid leukemia diagnosis can negatively affect patients and their loved ones’ mental health, but there are resources that can help.

The FDA approved Imfinzi plus carboplatin and paclitaxel followed by Imfinzi alone in patients with primary advanced or recurrent dMMR endometrial cancer.

As part of the CURE® Educated Patient® Summit, one expert reviewed the landscape of bispecific antibodies, such as Tecvayli, for multiple myeloma.

After having breast cancer, I worked on learning to accept and love myself.

From Kate Middleton giving an update on her cancer treatment to Kevin Jonas’ skin cancer surgery, here’s what’s happening in the oncology space this week.

I feel most thankful on Father's Day, especially after being told I'd never be able to have children.

Patients with chronic myeloid leukemia should be upfront with their care team about how treatment side effects are affecting their daily functioning.

Quality of life may temporarily worsen after patients with myeloma receive stem cell transplants, said an expert at the Educated Patient® Multiple Myeloma Summit.

My experience with non-Hodgkin lymphoma taught me to be grateful for the people I love and who love me.

The Food and Drug Administration approved Augtyro for patients over the age of 12 with NTRK-positive solid tumors.

The immunotherapy Opvido and reirradiation resulted in a one-year progression-free survival rate of 61.7% among certain patients with head and neck cancer.

Initial discussions about treatment, side effects and study results can help patients navigate through all aspects of a chronic myeloid leukemia diagnosis.

An advocate discusses vital patient-provider conversations to promote the best care for individuals with chronic myeloid leukemia.

The Food and Drug Administration granted a traditional approval to Retevmo for adult and pediatric patients 2 years old and older with advanced or metastatic RET fusion-positive thyroid cancer.

Meditation helped me quiet my mind and adopt a positive mindset after being diagnosed with cancer.

Having social media platforms to share breast cancer experiences changes the narrative for others who may empathize, a survivor and advocate said.

When I told my friends and family I have multiple myeloma, some of them didn't know what to do.